Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Charlotte Manisty; Ashley D. Otter; Thomas A. Treibel; Áine McKnight; Daniel M. Altmann; Timothy Brooks; Mahdad Noursadeghi; Rosemary J. Boyton; Amanda Semper; James C. Moon

doi:10.1016/S0140-6736(21)00501-8

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Charlotte Manisty, Ashley D. Otter, Thomas A. Treibel, Áine McKnight, Daniel M. Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J. Boyton, Amanda Semper, James C. Moon

Research output: Contribution to journal › Letter › peer-review

300 Citations (Scopus)

Original language	English
Pages (from-to)	1057-1058
Number of pages	2
Journal	The Lancet
Volume	397
Issue number	10279
DOIs	https://doi.org/10.1016/S0140-6736(21)00501-8
Publication status	Published - 20 Mar 2021

Access to Document

10.1016/S0140-6736(21)00501-8

Cite this

@article{aab7c417c641426f9473058611cf517a,

title = "Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals",

author = "Charlotte Manisty and Otter, \{Ashley D.\} and Treibel, \{Thomas A.\} and {\'A}ine McKnight and Altmann, \{Daniel M.\} and Timothy Brooks and Mahdad Noursadeghi and Boyton, \{Rosemary J.\} and Amanda Semper and Moon, \{James C.\}",

year = "2021",

month = mar,

day = "20",

doi = "10.1016/S0140-6736(21)00501-8",

language = "English",

volume = "397",

pages = "1057--1058",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10279",

}

TY - JOUR

T1 - Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

AU - Manisty, Charlotte

AU - Otter, Ashley D.

AU - Treibel, Thomas A.

AU - McKnight, Áine

AU - Altmann, Daniel M.

AU - Brooks, Timothy

AU - Noursadeghi, Mahdad

AU - Boyton, Rosemary J.

AU - Semper, Amanda

AU - Moon, James C.

PY - 2021/3/20

Y1 - 2021/3/20

UR - http://www.scopus.com/inward/record.url?scp=85102625202&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(21)00501-8

DO - 10.1016/S0140-6736(21)00501-8

M3 - Letter

C2 - 33640038

AN - SCOPUS:85102625202

SN - 0140-6736

VL - 397

SP - 1057

EP - 1058

JO - The Lancet

JF - The Lancet

IS - 10279

ER -

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals

Access to Document

Other files and links

Cite this